Stealth BioTherapeutics Announces Delay in FDA Action Date for  Barth Syndrome Application
Hand-out
Press Releases
April 29, 2025

Stealth BioTherapeutics Announces Delay in FDA Action Date for Barth Syndrome Application

- FDA decision on elamipretide for the treatment of Barth syndrome delayed -

bradford

The Bradford Era

Local & Social